Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canadá Association for Chronic Pain
NCT05125978Phase 2Withdrawn
- Sponsor
- EMS
- Start
- Sep 2026
- Primary completion
- Jul 2028
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, triple-blind trial of tramadol and Metamizole sodium in chronic pain (3 arms), sponsored by EMS. Primary endpoint: Difference in pain intensity assessed by the VAS scale at 12 weeks. Planned start Sep 2026; status: withdrawn.
02
Drugs
tramadolMetamizole sodium
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT05125978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05125978.